Mitomycin C and High-Dose 5-Fluorouracil With Folinic Acid as a Therapeutic Option for Heavily Pretreated Patients With Metastatic Colorectal Cancer: Prospective Phase II Trial

BACKGROUND. Standard treatment for patients with unresectable colorectal cancer metastases includes chemotherapy regimens based on irinotecan, oxaliplatin, fluoropyrimidines, anti-vascular endothelial growth factor therapy, and anti-EGFR. Additional therapeutic options are needed for patients with g...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Stec, Rafał, Bodnar, Lubomir, Smoter, Marta, Korniluk, Jan, Kuchar, Agata, Młot, Beata, Szczylik, Cezary
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2014
Témata:
Clinical Trial Results
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3983833/
https://ncbi.nlm.nih.gov/pubmed/24682464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0029
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky